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This Month in the Journal
USH3 Gene, by Joensuu et al. (p. 673)
Joensuu et al. add to the list of genes that are involved
in Usher syndrome, through their discovery of mutations,
in a novel gene, in people with Usher syndrome type 3.
The Usher syndromes are characterized by retinitis pig-
mentosa and sensorineural deafness. A founder mutation
for Usher syndrome type 3 exists in the Finnish popula-
tion, and this aided in the refinement of the critical region
for USH3. Contigs in this region were assembled, and
expressed-sequence tags (ESTs) were examined for mu-
tations. Three mutations in a retina-derived EST were
found in affected individuals. The major Finnish founder
mutation was a Y100X nonsense mutation. A second
founder mutation, M44K, was also identified in this pop-
ulation. Finally, a 3-bp deletion that resulted in the sub-
stitution of a methionine for an isoleucine and a leucine
was found in an Italian family. This gene, called “USH3,”
is predicted to be a transmembrane protein, and it has a
putative endoplasmic reticulum–retention signal. Mouse
models of other forms of Usher syndrome indicate that
some of the other genes that are associated with this dis-
order are involved in the development or maintenance of
the stereocilia in the ear. The USH3 protein and gene have
no homology to any known proteins or genes. As such,
it remains to be seen whether USH3 plays a similar role
or whether it is the key to the discovery of a new pathway
underlying the Usher syndromes.
Molecular Basis of Desmosterolosis, by Waterham et
al. (p. 685)
On the basis of similarity to an Arabidopsis thaliana en-
zyme, Waterham et al. have cloned and characterized the
gene responsible for desmosterolosis. This gene encodes
3b-hydroxysterol D24-reductase, an enzyme that catalyzes
one of the last steps in cholesterol biosynthesis. Desmo-
sterolosis was originally identified through its phenotypic
similarities to Smith-Lemli-Opitz syndrome (SLOS),
which results from a deficiency of 3b-hydroxysterol D7-
reductase. Both are malformation syndromes that affect
the development of such structures as the palate, limbs,
genitalia, head, and circulatory system. Despite the en-
zymatic deficiency that has been proposed on the basis
of biochemical data, the gene for desmosterolosis had
not been characterized until this study. The enzyme be-
lieved to be deficient in desmosterolosis, 3b-hydroxy-
sterol D24-reductase, reduces the D24 double bond of des-
mosterol during the production of cholesterol. DWF1
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catalyzes a very similar reduction reaction inA. thaliana,
and a putative human ortholog for DWF1 has been
known. Waterham et al. decided to study this human
ortholog to determine whether it is the gene responsible
for desmosterolosis. When expressed in Saccharomyces
cerevisiae, the enzyme encoded by this gene converts
desmosterol to cholesterol in an NADPH (reduced
nicotinamide adenine-dinucleotide phosphate)–depen-
dent, FAD (flavin adenine-dinucleotide)–enhanced re-
action. Mutations in this gene, which was dubbed
“DHCR24,” were found in two patients with desmos-
terolosis, and the proteins produced by these mutated
genes exhibited substantial reductions in enzymatic ac-
tivity in the S. cerevisiae expression system. The devel-
opment of SLOS and desmosterolosis in response to de-
ficiencies in cholesterol biosynthesis indicates that
cholesterol plays an important role in embryonic devel-
opment. However, its role in this process is not yet clear.
CNGA3 Mutations in Cone Photoreceptor Disorders,
by Wissinger et al. (p. 722)
The CNGA3 gene encodes the a-subunit of the cone-
photoreceptor cGMP-gated channel, which is crucial for
cone phototransduction in the eye. Mutations in this
gene, as well as some in the gene that encodes the b-
subunit of the same channel (CNGB3), have been found
in patients with complete achromatopsia, or total color
blindness. To define more clearly the spectrum of dis-
orders associated with mutations in CNGA3,Wissinger
et al. performed a large-scale mutation screen in people
with complete achromatopsia, incomplete achromatop-
sia, and progressive cone dystrophy. Mutations were
identified in 53 of 258 families, the majority being mis-
sense mutations. In fact, four recurrent missense muta-
tions account for almost 42% of those detected. Mu-
tations were not restricted to families with complete
achromatopsia but were found in families with all three
of the diagnoses that were examined. These resultswiden
the spectrum of phenotypic manifestations of mutations
in CNGA3.
Mismatch Repair in Colon Cancer, by Cunningham et
al. (p. 780)
Cunningham et al. have examined the prevalence of de-
fective DNA mismatch repair, as well as the mechanism
through which these defects occur, in a series of unselected
patients with colorectal cancer. Twenty percent of this
sample of 257 cases had defective DNA mismatch repair,
but germline mutations in the mismatch-repair genes
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hMLH1, hMSH2, and hMSH6 account for only ∼2%
of the total cases. Although somatic mutations in a mis-
match-repair gene were also responsible for some of the
mismatch-repair defects, promoter hypermethylation of
hMLH1 appears to be responsible for most of the cases
of DNA mismatch repair in these tumors. Defective mis-
match repair is one cause of hereditary nonpolyposis
colorectal cancer (HNPCC). This disorder is diagnosed
through use of a set of clinical criteria called the “Am-
sterdam criteria,” which includes an assessment of fam-
ily history of colon cancer. Cunningham et al. found that
not all patients with germline mutations in a mismatch-
repair gene fulfilled the Amsterdam criteria and that not
all cases that fulfilled these criteria had defective mis-
match repair. The authors propose that use of a molec-
ular diagnosis of hereditary defective mismatch-repair
syndrome, rather than HNPCC, might yield a more ho-
mogeneous group of patients and might facilitate the
identification of individuals at risk for cancer.
Linkage Disequilibrium Decay in Humans, by Frisse et
al. (p. 831)
Accurate characterization of population-specific linkage
disequilibrium (LD) across the genome is very important
for the design of disease-association studies. However,
different studies and different approaches to the char-
acterization of LD have yielded discrepant results. To be
able to make more-accurate comparisons between sam-
ples, Frisse et al. performed an empirical characterization
of LD in three distinct population samples: African,
Asian, and European. Sequence variation in the same 10
noncoding regions of the genome was analyzed in each
population, through the resequencing of these regions
in every individual in the sample. This allowed an ex-
amination of the spectrum of allele frequencies in the
different populations, as well as a comparison of the
amount of LDwith the amount of polymorphism in each
sample. Although, in these types of studies, non-African
populations are often grouped together for comparison
with African populations, frequency-spectra differences
between the Asian and European populations in this
study imply that different population histories may have
shaped the two groups and that the “non-African”
group is not uniform. Because gene conversion is likely
to play a role in the decay of LD, Frisse et al. used their
data to estimate the parameters of the gene-conversion
process. The amount of gene conversion calculated from
their human sample was higher than that which previ-
ously had been estimated in model organisms, such as
Drosophila and yeast. These new estimates of the extent
of gene conversion in humans should allow more-ac-
curate predictions, through computer simulation, of ge-
nomewide patterns of LD. Previous predictions of the
extent of genomewide LD, which have been based on
computer simulation (see the Kruglyak [1999] reference
cited by Frisse et al.), are upheld in the African sample
in the study by Frisse et al., in which relatively low levels
of LD were observed. However, LD in the non-African
samples was much higher than that predicted by the
simulations. These results indicate that the marker den-
sity required for association studies will vary according
to the population under examination, with African pop-
ulations requiring a marker density much higher than
that required by non-African populations.
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